img

FAQs

FREQUENTLY ASKED QUESTIONS

Semaglutide is a medication used to treat type 2 diabetes and obesity. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide works by mimicking the action of a natural hormone called GLP-1, which helps reduce appetite and promote weight loss.

Semaglutide is not a type of insulin. It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. While both insulin and GLP-1 receptor agonists are used to manage blood sugar levels, they work in different ways.

Semaglutide is not a stimulant. It is a medication classified as a glucagon-like peptide-1 (GLP-1) receptor agonist. While some stimulant medications may have appetite-suppressing effects, Semaglutide’s mechanism of action is different.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor that targets an area in the brain to regulate your appetite and how much you eat, thus promoting weight loss. This closely mimics a natural hormone in the body called incretin, which is made primarily in our digestive tract.

Semaglutide for weight loss is typically recommended for adults with a body mass index (BMI) of 30 or higher or for those with a BMI of 27 or higher who have weight-related conditions. Consult a healthcare provider to determine if it’s suitable for your specific needs.

Semaglutide has shown significant effectiveness for weight loss in non-diabetic individuals. Clinical trials have demonstrated substantial weight reduction, making it a promising option for those seeking to manage obesity and achieve healthier body weight.

Do not place them near the refrigerator cooling element, you can store unused semaglutide pens (Ozempic) in the refrigerator (36°F to 46°F [2°C to 8°C]). Once it is in use, you can simply store it at room temperature (59°F to 86°F [15°C to 30°C]) or in the refrigerator.

When taking Semaglutide for weight loss, you can expect several potential effects and benefits, such as weight loss, reduced appetite, improved blood sugar control, and some potential side effects, including nausea, vomiting, diarrhea, and constipation.

This medicine is taken as a subcutaneous injection under the skin of your stomach, thighs, or upper arm.

The duration of Semaglutide use for weight loss varies but is typically prescribed for an initial period of 16-20 weeks. After this period, your healthcare provider will assess your progress and determine if continued treatment is necessary.

Some of the most common side effects of Semaglutide include dizziness, fatigue, headache, vomiting, and gastrointestinal issues, such as diarrhea, constipation, and gassiness.

The most common long-term effect is gastrointestinal disorders. Common side effects of semaglutide may be a reaction to changes in blood sugar, an induced boost in insulin production, and rapid weight loss.